Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT00841035
Brief Title: 7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients

First Submitted : February 9, 2009
First Submitted that Met QC Criteria : February 10, 2009
First Posted : February 11, 2009 (Estimate)

Results First Submitted : July 3, 2013
Results First Submitted that Met QC Criteria : September 29, 2014
Results First Posted : October 6, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : April 17, 2017
Last Update Posted : May 19, 2017